Skip to content

Digital Health Implementation Strategies to Improve Lung Cancer Screening Among Safety-Net Clinics

Digital Health Implementation Strategies to Improve Lung Cancer Screening Among Safety-Net Clinics (LUNG-IS) - PATIENT

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07716280
Acronym
LUNG-IS
Enrollment
800
Registered
2026-07-21
Start date
2026-01-01
Completion date
2027-01-01
Last updated
2026-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Brief summary

The long-term goal of this program of research is to increase the reach of Lung Cancer Screening (LCS) among low-resource healthcare settings and populations. The proposed project, LUNG-IS, is a mixed-methods, pre-post quasi-experimental design conducted in three Utah safety-net healthcare system clinics. LUNG-IS employs a comprehensive conceptual model with theories, models, and frameworks of implementation and behavioral science, uses rigorous mixed-methods to evaluate factors that influence implementation of LCS, and uses patient navigation to facilitate clinic-community linkages. LUNG-IS leverages existing pathways to care and Centralized Hub infrastructure that enables eligibility assessment, LCS Shared Decision Making (SDM) with clinical decision support, screening referral, and screening logistics assistance to help overcome barriers to LCS completion. The Centralized Hub model uses ubiquitous technologies (i.e., text messaging/telehealth) to enable patients to be assessed for LCS eligibility, engage in SDM if eligible, and be referred for LCS. For patients who decide to complete LCS, they will be provided patient navigation via Community Health Workers designed to address logistical barriers, hesitancy, and financial constraints around completing LCS.

Interventions

Basic text messages sent directly to the patient's cell phone.

BEHAVIORALChat bot (CA)

Chat bot to answer frequently asked LCS questions.

BEHAVIORALVideo

Educational video about LCS.

Reactive patient navigation to help get to the LCS appointment.

Proactive patient navigation to help get to the LCS appointment.

Sponsors

University of Utah
Lead SponsorOTHER
Centers for Disease Control and Prevention
CollaboratorFED

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
50 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Current or former, male and female, smokers. * Age 50-80. * Primary language English or Spanish. * Have a phone that can send/receive text messages.

Exclusion criteria

* Patients who have never smoked. * Patients who are under the age of 50 or above the age of 80. * Primary language other than English or Spanish. * Do not have access to a phone that can send/receive text messages.

Design outcomes

Primary

MeasureTime frameDescription
Impact of Implementation Strategies on Lung Cancer Screening (LCS) eligibility screeningup to 15 weeks after study enrollmentEvaluate the impact of implementation strategies on Lung Cancer Screening (LCS) eligibility screening. This outcome measure will report the proportion of participants who complete LCS eligibility screening.

Secondary

MeasureTime frameDescription
Impact of Implementation Strategies on LCS Shared Decision Making (SDM) completionup to 7 weeks after completion of LCS eligibility screenEvaluate the impact of implementation strategies on Shared Decision Making (SDM) completion. This outcome measure will report the proportion of patients who complete SDM.
Impact of Implementation Strategies on LCS Completionup to 6 months after placement of LCS referralEvaluate the impact of implementation strategies on LCS completion. This outcome measure will report the proportion of participants who complete LCS.

Countries

United States

Contacts

CONTACTIndy Li, MS
indy.li@hci.utah.edu801-213-5697
PRINCIPAL_INVESTIGATORChelsey Schlechter, MPH, PhD

Huntsman Cancer Institute/ University of Utah

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 22, 2026